Sonjoy Raja Laskar, MD

Emory Clinic

Associate Professor of Medicine

Emory Healthcare Network Physician
Advanced Heart Failure & Transplant Cardiology (Board certified since 2012)
Cardiology (Board certified since 2003)
Internal Medicine (Board certified since 1999)
Areas of Clinical Interest:
cardiac transplant
cardiology - general
heart failure/heart transplant
Office(s) Locations:
Emory Heart & Vascular Center at Midtown
550 Peachtree St NE
Atlanta, GA 30308
404 686-7885

Emory Heart & Vascular Center at Clifton
1365 Clifton Rd NE Bldg A
Atlanta, GA 30322
404 778-5268
About Dr. Laskar

Dr. Laskar is the Medical Director of the Emory Healthcare VAD Program.  Dr. Laskar has demonstrated a true devotion to providing direct care to patients with heart failure, heart transplantation or ventricular assist devices, and teaching residents and fellows. Dr. Laskar also travels throughout Georgia and South Carolina providing education to physicians about treatment options available for patients with heart failure. Dr. Laskar is an active researcher in the areas of echocardiography and ventricular assist devices as destination therapy. Dr. Laskar is also board certified in Advanced Heart Failure and Transplant Cardiology.

Year Started Practicing: 1999
Year Started Practicing at Emory: 2004
Organizational Memberships:
American College of Cardiology
Heart Failure Society of America
International Society of Heart/Lung Transplant
Major or Recent Publications:

Laskar S.R., Grayburn PA. “Assessment of Myocardial Perfusion with Contrast Echocardiography at Rest and with Stress: An Emerging Technology.” Prog in Card Disease 2000; 43: 245-258.

Laskar S.R., Dries D. “The Prognostic Impact of Renal Dysfunction in Patients with Chronic Systolic Heart Failure.” Curr Cardiol Report 2003; 5 (3): 205-210.

Yancy CW, Laskar S.R., Eichorn E. “The use of beta-adrenergic antagonists in African Americans with heart failure.” Congestive Heart Failure 2004; 10 (1) 34-37.

Kamanth, S.K., Laskar S.R., Yancy C.W. “Novel therapies for heart failure: vasopressin and selective Aldosterone antagonists.” Congestive Heart Failure 2005; 11: (1) 21-29.

Baseman D.G, O’Suilleabhain P.E., Reimold S.C., Laskar S.R., Baseman J.G., Dewey R.B. “Using Pergolide in Parkinson’s Disease is Associated with Significant Cardiac Valve Regurgitation.” Neurology 2004; 63 (2) :301-4.

Medical School
Emory University School of Medicine, Atlanta, GA

University of Texas Southwestern Medical Center, Dallas, TX

University of Texas Southwestern Medical Center, Dallas, TX

University of Texas Southwestern Medical Center, Dallas, TX